From: Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PSMA
Condition
Gentisic acid (mM)
Ascorbate (mM)
Ethanol % (v/v)
RCP (%)
t0 (n = 3)
t4 (n = 2)
t24 (n = 2)
6
9.0
35.4
10
98.7 ± 0.4
97.4 ± 0.8
94.1 ± 1.2